Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BFB Health's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 425.78.
BFB Health's Days Inventory for the
six
months ended in Dec. 2025 was 76.39.
BFB Health's Days Payable for the
six
months ended in Dec. 2025 was 400.67.
Therefore, BFB Health's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was 101.50.
BFB Health (HKSE:00205) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
BFB Health Cash Conversion Cycle Related Terms
BFB Health Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for BFB Health's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00205 vs APP, OMC, TTD: Cash Conversion Cycle Comparison
For the Advertising Agencies subindustry, BFB Health's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BFB Health Cash Conversion Cycle vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, BFB Health's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where BFB Health's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
BFB Health's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFB Health (HKSE:00205) has a Cash Conversion Cycle of 101.50 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on BFB Health and its competitors.
Is BFB Health's Cash Conversion Cycle too high?
BFB Health's current Cash Conversion Cycle is 101.50. The Media - Diversified industry median Cash Conversion Cycle is 19.47. BFB Health's value of 101.50 is 421.3% above this industry median. Overall, BFB Health has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BFB Health's Cash Conversion Cycle compare to APP and OMC?
BFB Health's Cash Conversion Cycle of 101.50 can be compared against companies in the Media - Diversified industry. The industry median Cash Conversion Cycle is 19.47. BFB Health's value of 101.50 is 421.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Media - Diversified company?
The median Cash Conversion Cycle among Media - Diversified companies is 19.47, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BFB Health's current Cash Conversion Cycle of 101.50 is 421.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on BFB Health and its competitors. For the Media - Diversified industry, the median Cash Conversion Cycle is 19.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BFB Health's current Cash Conversion Cycle is 101.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BFB Health stock overvalued right now?
Based on GuruFocus' analysis, BFB Health (HKSE:00205) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.57 — trading 303.6% above its estimated fair value. The current Cash Conversion Cycle is 101.50 and 421.3% above the Media - Diversified industry median of 19.47. BFB Health's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For BFB Health (HKSE:00205), the current Cash Conversion Cycle is 101.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BFB Health (HKSE:00205) Overvalued in 2026?
Based on GuruFocus' analysis, BFB Health stock appears to be overvalued.
The current stock price of HK$0.57 is trading 303.6% above its estimated GF Value™ of HK$0.14.
GuruFocus considers BFB Health to be Significantly Overvalued.
Key valuation signals for HKSE:00205:
Cash Conversion Cycle: 101.50
GF Value™: HK$0.14 vs. price of HK$0.57 (303.6% above fair value)
Industry Position: 421.3% above the Media - Diversified median
No single metric tells the full story. See the HKSE:00205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BFB Health Ltd is an investment holding company. Along with its subsidiaries, it operates in the following reportable segments: Provision of advertising and e-commerce business, Provision of securities broking services, and Money lending. Maximum revenue is derived from the Provision of advertising and e-commerce business, which generates the majority of its revenue from the sales of health and wellness products, through e-commerce channels, and the rest comes from the provision of advertising services, sales of books and magazines, and multi-channel network activities. Geographically, the Group generates maximum revenue from the People's Republic of China (PRC), and the rest from Hong Kong.
36GF Score
Get the complete analysis for HKSE:00205
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00205 has been successfully added to your 
